Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism

FEBS Letters

Volumn 579, Issue 5, 2005, Pages 1227-1234

  Yao, Yong Gang ^a   Yang, Hoseong S ^a   Cao, Zhiming ^a   Danielsson, Jennifer ^a   Duh, Elia J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Angiogenesis; Endothelial cell; Placental growth factor; Proliferative diabetic retinopathy; Protein kinase C; Vascular endothelial growth factor

Indexed keywords

CALCIMYCIN; CALCIUM IONOPHORE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PLACENTAL GROWTH FACTOR; PROTEIN KINASE C; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA CELL; RETINOPATHY; STATISTICAL SIGNIFICANCE; UMBILICAL VEIN; UPREGULATION;

EID: 13844282129     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.01.017     Document Type: Article

References (53)

1. A.P. Adamis, J.W. Miller, M.T. Bernal, D.J. D'Amico, J. Folkman, T.K. Yeo, and K.T. Yeo Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am. J. Ophthalmol. 118 1994 445 450
2. L.P. Aiello, R.L. Avery, P.G. Arrigg, B.A. Keyt, H.D. Jampel, S.T. Shah, L.R. Pasquale, H. Thieme, M.A. Iwamoto, and J.E. Park Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N. Engl. J. Med. 331 1994 1480 1487
3. J.W. Miller, A.P. Adamis, D.T. Shima, P.A. D'Amore, R.S. Moulton, M.S. O'Reilly, J. Folkman, H.F. Dvorak, L.F. Brown, and B. Berse Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model Am. J. Pathol. 145 1994 574 584
4. E.A. Pierce, R.L. Avery, E.D. Foley, L.P. Aiello, and L.E. Smith Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc. Natl. Acad. Sci. USA 92 1995 905 909
5. T. Tobe, N. Okamoto, M.A. Vinores, N.L. Derevjanik, S.A. Vinores, D.J. Zack, and P.A. Campochiaro Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors Invest. Ophthalmol. Vis. Sci. 39 1998 180 188
6. L.P. Aiello, E.A. Pierce, E.D. Foley, H. Takagi, H. Chen, L. Riddle, N. Ferrara, G.L. King, and L.E. Smith Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins Proc. Natl. Acad. Sci. USA 92 1995 10457 10461
7. A.P. Adamis, D.T. Shima, M.J. Tolentino, E.S. Gragoudas, N. Ferrara, J. Folkman, P.A. D'Amore, and J.W. Miller Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate Arch. Ophthalmol. 114 1996 66 71
8. G.S. Robinson, E.A. Pierce, S.L. Rook, E. Foley, R. Webb, and L.E. Smith Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy Proc. Natl. Acad. Sci. USA 93 1996 4851 4856
9. M.S. Seo, N. Kwak, H. Ozaki, H. Yamada, N. Okamoto, E. Yamada, D. Fabbro, F. Hofmann, J.M. Wood, and P.A. Campochiaro Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor Am. J. Pathol. 154 1999 1743 1753
10. H. Ozaki, M.S. Seo, K. Ozaki, H. Yamada, E. Yamada, N. Okamoto, F. Hofmann, J.M. Wood, and P.A. Campochiaro Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization Am. J. Pathol. 156 2000 697 707
11. S. De Falco, B. Gigante, and M.G. Persico Structure and function of placental growth factor Trends Cardiovasc. Med. 12 2002 241 246
12. P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, M. De Mol, Y. Wu, F. Bono, L. Devy, H. Beck, D. Scholz, T. Acker, T. DiPalma, M. Dewerchin, A. Noel, I. Stalmans, A. Barra, S. Blacher, T. Vandendriessche, A. Ponten, U. Eriksson, K.H. Plate, J.M. Foidart, W. Schaper, D.S. Charnock-Jones, D.J. Hicklin, J.M. Herbert, D. Collen, and M.G. Persico Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat. Med. 7 2001 575 583
13. J.M. Rakic, V. Lambert, L. Devy, A. Luttun, P. Carmeliet, C. Claes, L. Nguyen, J.M. Foidart, A. Noel, and C. Munaut Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization Invest. Ophthalmol. Vis. Sci. 44 2003 3186 3193
14. H. Oura, J. Bertoncini, P. Velasco, L.F. Brown, P. Carmeliet, and M. Detmar A critical role of placental growth factor in the induction of inflammation and edema formation Blood 101 2003 560 567
15. A. Luttun, M. Tjwa, L. Moons, Y. Wu, A. Angelillo-Scherrer, F. Liao, J.A. Nagy, A. Hooper, J. Priller, B. De Klerck, V. Compernolle, E. Daci, P. Bohlen, M. Dewerchin, J.M. Herbert, R. Fava, P. Matthys, G. Carmeliet, D. Collen, H.F. Dvorak, D.J. Hicklin, and P. Carmeliet Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Nat. Med. 8 2002 831 840
16. F. Pipp, M. Heil, K. Issbrucker, T. Ziegelhoeffer, S. Martin, J. van den Heuvel, H. Weich, B. Fernandez, G. Golomb, P. Carmeliet, W. Schaper, and M. Clauss VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism Circ. Res. 92 2003 378 385
17. M. Autiero, J. Waltenberger, D. Communi, A. Kranz, L. Moons, D. Lambrechts, J. Kroll, S. Plaisance, M. De Mol, F. Bono, S. Kliche, G. Fellbrich, K. Ballmer-Hofer, D. Maglione, U. Mayr-Beyrle, M. Dewerchin, S. Dombrowski, D. Stanimirovic, P. Van Hummelen, C. Dehio, D.J. Hicklin, G. Persico, J.M. Herbert, M. Shibuya, D. Collen, E.M. Conway, and P. Carmeliet Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 Nat. Med. 9 2003 936 943
18. A. Luttun, M. Autiero, M. Tjwa, and P. Carmeliet Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets Biochim. Biophys. Acta 1654 2004 79 94
19. L.E. Smith, E. Wesolowski, A. McLellan, S.K. Kostyk, R. D'Amato, R. Sullivan, and P.A. D'Amore Oxygen-induced retinopathy in the mouse Invest. Ophthalmol. Vis. Sci. 35 1994 101 111
20. P. Gehlbach, A.M. Demetriades, S. Yamamoto, T. Deering, E.J. Duh, H.S. Yang, C. Cingolani, H. Lai, L. Wei, and P.A. Campochiaro Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization Gene Ther. 10 2003 637 646
21. Y. Cao, W.R. Ji, P. Qi, and A. Rosin Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing Biochem. Biophys. Res. Commun. 235 1997 493 498
22. W. Yang, H. Ahn, M. Hinrichs, R.J. Torry, and D.S. Torry Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells J. Reprod. Immunol. 60 2003 53 60
23. Y.G. Yao, and E.J. Duh VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis? Biochem. Biophys. Res. Commun. 321 2004 648 656
24. D.A. Simpson, S. Feeney, C. Boyle, and A.W. Stitt Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR Mol. Vis. 6 2000 178 183
25. H. Yonekura, S. Sakurai, X. Liu, H. Migita, H. Wang, S. Yamagishi, M. Nomura, M.J. Abedin, H. Unoki, Y. Yamamoto, and H. Yamamoto Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis J. Biol. Chem. 274 1999 35172 35178
26. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
27. N. Ferrara Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev. 25 2004 581 611
28. J.E. Park, H.H. Chen, J. Winer, K.A. Houck, and N. Ferrara Placenta growth factor Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR J. Biol. Chem. 269 1994 25646 25654
29. A. Luttun, K. Brusselmans, H. Fukao, M. Tjwa, S. Ueshima, J.M. Herbert, O. Matsuo, D. Collen, P. Carmeliet, and L. Moons Loss of placental growth factor protects mice against vascular permeability in pathological conditions Biochem. Biophys. Res. Commun. 295 2002 428 434
30. T. Odorisio, C. Schietroma, M.L. Zaccaria, F. Cianfarani, C. Tiveron, L. Tatangelo, C.M. Failla, and G. Zambruno Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability J. Cell Sci. 115 2002 2559 2567
31. P.N. Tsao, Y.N. Su, H. Li, P.H. Huang, C.T. Chien, Y.L. Lai, C.N. Lee, C.A. Chen, W.F. Cheng, S.C. Wei, C.J. Yu, F.J. Hsieh, and S.M. Hsu Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema Am. J. Respir. Crit. Care Med. 169 2004 505 511
32. A. Khaliq, D. Foreman, A. Ahmed, H. Weich, Z. Gregor, D. McLeod, and M. Boulton Increased expression of placenta growth factor in proliferative diabetic retinopathy Lab. Invest. 78 1998 109 116
33. B. Zhao, J. Cai, and M. Boulton Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2 Microvasc. Res. 68 2004 239 246
34. H. Ishii, M.R. Jirousek, D. Koya, C. Takagi, P. Xia, A. Clermont, S.E. Bursell, T.S. Kern, L.M. Ballas, W.F. Heath, L.E. Stramm, E.P. Feener, and G.L. King Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor Science 272 1996 728 731
35. L.P. Aiello, S.E. Bursell, A. Clermont, E. Duh, H. Ishii, C. Takagi, F. Mori, T.A. Ciulla, K. Ways, M. Jirousek, L.E. Smith, and G.L. King Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor Diabetes 46 1997 1473 1480
36. D. Koya, and G.L. King Protein kinase C activation and the development of diabetic complications Diabetes 47 1998 859 866
37. K. Suzuma, N. Takahara, I. Suzuma, K. Isshiki, K. Ueki, M. Leitges, L.P. Aiello, and G.L. King Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization Proc. Natl. Acad. Sci. USA 99 2002 721 726
38. L.P. Aiello The potential role of PKC beta in diabetic retinopathy and macular edema Surv. Ophthalmol. 47 Suppl 2 2002 S263 S269
39. L.P. Aiello, M.T. Cahill, and J.D. Cavallerano Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy Eye 18 2004 117 125
40. K.R. Tuttle, and P.W. Anderson A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition Am. J. Kidney Dis. 42 2003 456 465
41. Z. He, and G.L. King Protein kinase Cbeta isoform inhibitors: a new treatment for diabetic cardiovascular diseases Circulation 110 2004 7 9
42. A. Nonaka, J. Kiryu, A. Tsujikawa, K. Yamashiro, K. Miyamoto, H. Nishiwaki, Y. Honda, and Y. Ogura PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats Invest. Ophthalmol. Vis. Sci. 41 2000 2702 2706
43. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
44. L.P. Aiello Clinical implications of vascular growth factors in proliferative retinopathies Curr. Opin. Ophthalmol. 8 1997 19 31
45. S.J. Mandriota, and M.S. Pepper Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia Circ. Res. 83 1998 852 859
46. H. Oh, H. Takagi, K. Suzuma, A. Otani, M. Matsumura, and Y. Honda Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells J. Biol. Chem. 274 1999 15732 15739
47. K. Suzuma, K. Naruse, I. Suzuma, N. Takahara, K. Ueki, L.P. Aiello, and G.L. King Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase- akt-dependent pathways in retinal vascular cells J. Biol. Chem. 275 2000 40725 40731
48. S. He, M.L. Jin, V. Worpel, and D.R. Hinton A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization Arch. Ophthalmol. 121 2003 1283 1288
49. A.L. Armesilla, E. Lorenzo, P. Gomez del Arco, S. Martinez-Martinez, A. Alfranca, and J.M. Redondo Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression Mol. Cell Biol. 19 1999 2032 2043
50. G.L. Hernandez, O.V. Volpert, M.A. Iniguez, E. Lorenzo, S. Martinez-Martinez, R. Grau, M. Fresno, and J.M. Redondo Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2 J. Exp. Med. 193 2001 607 620
51. T.H. Lee, H. Avraham, S.H. Lee, and S. Avraham Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells J. Biol. Chem. 277 2002 10445 10451
52. M. Abe, and Y. Sato cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells Angiogenesis 4 2001 289 298
53. D. Liu, H. Jia, D.I. Holmes, A. Stannard, and I. Zachary Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1 Arterioscler. Thromb. Vasc. Biol. 23 2003 2002 2007